What's Hydroxychloroquine?

It is an antimalarial medication that can also be employed to treat autoimmune conditions such as arthritis, rheumatoid, and Lupus. It's available in tablets and operates by inhibiting the immune system, as well as decreasing inflammation.

What's what is the Hydroxychloroquine market?

Hydroxychloroquine market is the world market for the production, distribution, and sales of Hydroxychloroquine as a drug. It encompasses both brands as well as generic versions of the medicine.

What was the reason for Hydroxychloroquine being featured in the news?

The drug received significant public attention in the context of the COVID-19 epidemic. A few early studies as well as anecdotal studies suggested it could offer a potential treatment for COVID-19. However, the subsequent studies and clinical studies yielded inconsistent or even negative findings. There was controversy over its use for COVID-19 prompting a rise in the public's awareness and scrutiny.

Global Hydroxychloroquine Market By Type (Tablet and Active Pharmaceutical Ingredients), By Disease Indication (Malaria, Lupus Erythematosus, COVID-19, Rheumatoid Arthritis, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Oct 2023
Report ID: 101811
Number of Pages: 295
Format:

- Sanofi S.A.
- Sandoz International GmbH
- Ipca Laboratories Limited
- Mylan N.V.
- Teva Pharmaceutical Industries Limited
- Bayer AG Company Profile
- Zydus Lifesciences Limited
- Hikama Pharmaceuticals plc.
- Pfizer Inc Company Profile
- Torrent Pharmaceutical Ltd
- Zydus Pharmaceutical Inc.
- Amneal Pharmaceuticals LLC
- Torrent Pharmaceuticals Ltd Company Profile
- Taj Pharmaceuticals Ltd.
- Cadila Healthcare Ltd.
- Cipla Inc.
- Accord Healthcare Inc.
- Other Key Player
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 101811
Published Date Oct 2023
Rating
- ★★★★★
  
  ★★★★★
- (37)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)